2023-10-07 06:42:32
Disappeared from the shelves just ten days following it was put on the market! it is not the new iPhone nor the latest pair of Nikes, but Nirsevimab, the first preventive treatment intended for infants which has enjoyed phenomenal success since it was made available in France in mid-September, under the trade name Beyfortus. The 200,000 doses ordered have already been sold out, in just over a week. The Minister of Health Aurélien Rousseau welcomed an “exceptional success” and a “very high support rate” from parents, close to 95%. The demand is such that it was necessary to reserve the reduced doses for maternity hospitals, while waiting for resupplies. “200,000 doses ordered for 700,000 children potentially affected: once once more
1696678878
#Health #Rush #nirsevimab #Beyfortus #preventative #treatment #bronchiolitis
